HD Medicine, or Huadong Medicine Co., Ltd., is a Hangzhou-based pharmaceutical company registered on the Shenzhen Stock Exchange since January 27, 2000. It has a listed share capital of 380,000,000 renminbi and a market capitalization of 126,323,040 renminbi as of July 2005. It is the largest pharmaceutical company in Zhejiang and the leading immunosuppressant manufacturer in China.[1]
In June 2025, the company received approval to commence clinical trials for Roflumilast Foam, targeting dermatological conditions. [2]
References
- China Listed Companies Handbook (Vol 4) Javvin Technologies, 2008^
- M. T. Newswires. Huadong Medicine Gets Clinical Trial Approval for Roflumilast Foam www.marketscreener.com, 2025-06-11, retrieved 2025-06-26^